Not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.
PSC Trial Watch
IBD (general)Recruiting

Characterization of Phenotype and Genotype of Early Onset Enteropathies

Observational · No treatment assigned · 12 sites · Imagine Institute

Official record & contacts on ClinicalTrials.gov ↗

In plain English

What this trial is testing

Condition(s) listed: Inflammatory Bowel Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.

Who can join

Some of the main requirements, copied from the record:

Plus 3 more requirement(s). Only the trial team can confirm whether you qualify.

What's involved

Main thing being measured

In the researchers’ words

This study has been set up in order to characterize phenotypes and genotypes of patients with early onset enteropathies. In that goal, Investigators will collect biological samples (mainly blood) of patients suffering from early onset enteropathies and their healthy relatives.

This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.

Questions to ask your doctor and the trial team

Official details

StatusRecruiting
PhaseObservational
Study typeObservational
ConditionsInflammatory Bowel Disease
Lead sponsorImagine Institute
Enrollment1445 (estimated)
Start date2014-06-16
Primary completion (est.)2054-06-15
First posted2015-11-25
Last updated2025-04-30
Official titleHost-Microbiota Interactions Across the Gut Immune System: Characterization of Phenotype and Genotype of Early Onset Enteropathies
ClinicalTrials.gov IDNCT02614911

Interventions

Full eligibility criteria (from the record)
Main Inclusion Criteria:

* Severe chronic enteropathy
* Patients developing their first symptoms within the first 6 years of life and, in priority within the first two years of life, or patients with a disease of later onset, in case of a familial history suggestive of inherited mutations notably in families comprising several affected members
* OR : Be a patient's relative, even if presenting with enteropathy of later onset.

Main Exclusion Criteria:

* Subject having participated to any therapeutical clinical study in the 30 days preceding the inclusion in this study,

Locations (12)

SiteCityCountrySite status
Centre Hospitalier Pellegrin-EnfantsBordeauxFranceRecruiting
Hôpital pédiatrique de LyonBronFranceRecruiting
Hôpital Jeanne de Flandre, CHRU de LilleLilleFranceRecruiting
Hôpital d'enfants de la TimoneMarseilleFranceRecruiting
Hôpital Saint AntoineParisFranceRecruiting
Necker - Enfants Malades HospitalParisFranceRecruiting
Hôpital Robert DebréParisFranceRecruiting
Hôpital TrousseauParisFranceRecruiting
Hôpital SudRennesFranceRecruiting
CHU HautepierreStrasbourgFranceNot yet recruiting
Hôpital des EnfantsToulouseFranceRecruiting
Hôpital Clocheville, CHU de ToursToursFranceRecruiting

For contacts at each site, use the official record.

Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.